IONS logo

Ionis Pharmaceuticals Inc (IONS)

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the trea...

NASDAQHealthcareBiotechnologyUSA

公司簡介

股票程式碼
IONS
ISIN程式碼
US4622221004
貨幣
US Dollar (USD)
IPO日期
1991-05-17

聯絡資訊

公司地址
2855 Gazelle Court, Carlsbad, CA, United States, 92010
聯絡電話
760 931 9200
公司網站
https://www.ionis.com
財年結束
December

財務亮點

市值
$999,999.99
毛利潤(TTM)
$-999,999.99
資產回報率(TTM)
-12.43%
EBITDA
$-999,999.99
收入(TTM)
$999,999.99